Osteoarthritis (OA) is currently defined by the American College of Rheumatology as a “heterogeneous
group of conditions that leads to joint symptoms and signs which are associated …

We have read with interest the recent article by Favalli et al. published in Autoimmunity Reviews
[1]. We agree with the Authors that Corona Virus Disease 2019 (COVID-19) pandemic is …

One hundred and eighty patients with psoriasis have been studied in the Neapolitan area to
find the prevalence of arthritis in psoriasis. Wright and Moll's criteria for the diagnosis of …

Introduction: Five anti-tumor necrosis factor (anti-TNF) agents have received regulatory
approval for use in rheumatology: adalimumab, golimumab, infliximab, certolizumab, and …

Objectives To evaluate prospectively the effect of weight loss on the achievement of minimal
disease activity (MDA) in overweight/obese patients with psoriatic arthritis (PsA) starting …

Objective To evaluate colonic mucosa of patients with both active psoriasis and psoriatic
arthritis (PsA) without bowel symptoms. Methods Fifteen persons (9 men, 6 women) who had …

Objective We prospectively evaluated whether obesity impacts achievement of minimal
disease activity (MDA) in subjects with psoriatic arthritis (PsA). Methods Among PsA subjects …

Objective— Subjects with psoriatic arthritis (PsA) have an abnormally high prevalence of
vascular risk factors (VRFs) and are predisposed to vascular mortality. Tumor necrosis factor (…

Objective. During OMERACT 8, delegates selected patient global assessment (PGA) of
disease as a domain to be evaluated in randomized controlled trials in psoriatic arthritis (PsA). …

OBJECTIVE: Osteoarthritis (OA) has been identified as the disease with the highest rate of
comorbidities, which may increase the likelihood of disability. The AMICA study evaluated …